A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Clinical trial NCT02293395 · COMPLETED
Trial details
- NCT number
- NCT02293395
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-20
- Primary completion
- 2016-10-14
- Enrollment
- 3037
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.